Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial.
Faghfouri AH, Baradaran B, Khabbazi A, Abdoli Shadbad M, Papi S, Faghfuri E, Khajebishak Y, Rahmani S, Tolou Hayat P, Alipour B. Faghfouri AH, et al. Among authors: abdoli shadbad m. Int Immunopharmacol. 2022 Aug;109:108825. doi: 10.1016/j.intimp.2022.108825. Epub 2022 May 10. Int Immunopharmacol. 2022. PMID: 35561480 Clinical Trial.
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines.
Lotfinejad P, Kazemi T, Safaei S, Amini M, Roshani Asl E, Baghbani E, Sandoghchian Shotorbani S, Jadidi Niaragh F, Derakhshani A, Abdoli Shadbad M, Silvestris N, Baradaran B. Lotfinejad P, et al. Among authors: abdoli shadbad m. Biomed Pharmacother. 2021 Jun;138:111436. doi: 10.1016/j.biopha.2021.111436. Epub 2021 Mar 2. Biomed Pharmacother. 2021. PMID: 33667790 Free article.
Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?
Hosseinkhani N, Derakhshani A, Kooshkaki O, Abdoli Shadbad M, Hajiasgharzadeh K, Baghbanzadeh A, Safarpour H, Mokhtarzadeh A, Brunetti O, Yue SC, Silvestris N, Baradaran B. Hosseinkhani N, et al. Among authors: abdoli shadbad m. Int J Mol Sci. 2020 Nov 5;21(21):8305. doi: 10.3390/ijms21218305. Int J Mol Sci. 2020. PMID: 33167514 Free PMC article. Review.
The oncogenic potential of NANOG: An important cancer induction mediator.
Najafzadeh B, Asadzadeh Z, Motafakker Azad R, Mokhtarzadeh A, Baghbanzadeh A, Alemohammad H, Abdoli Shadbad M, Vasefifar P, Najafi S, Baradaran B. Najafzadeh B, et al. Among authors: abdoli shadbad m. J Cell Physiol. 2021 Apr;236(4):2443-2458. doi: 10.1002/jcp.30063. Epub 2020 Sep 22. J Cell Physiol. 2021. PMID: 32960465 Review.
The role of CD44 in cancer chemoresistance: A concise review.
Yaghobi Z, Movassaghpour A, Talebi M, Abdoli Shadbad M, Hajiasgharzadeh K, Pourvahdani S, Baradaran B. Yaghobi Z, et al. Among authors: abdoli shadbad m. Eur J Pharmacol. 2021 Jul 15;903:174147. doi: 10.1016/j.ejphar.2021.174147. Epub 2021 May 5. Eur J Pharmacol. 2021. PMID: 33961871 Review.
25 results